Literature DB >> 22106348

Intraoperative microwave ablation of pulmonary malignancies with tumor permittivity feedback control: ablation and resection study in 10 consecutive patients.

Farrah J Wolf1, Bassam Aswad, Thomas Ng, Damian E Dupuy.   

Abstract

PURPOSE: To determine histologic changes induced by microwave ablation (MWA) in patients with pulmonary malignancy by using an ablation system with tumor permittivity feedback control, enabling real-time modulation of energy power and frequency.
MATERIALS AND METHODS: Institutional review board approval and patient informed consent were obtained for this prospective HIPAA-complaint ablation and resection study. Between March 2009 and January 2010, 10 patients (four women, six men; mean age, 71 years; age range, 52-82 years) underwent intraoperative MWA of pulmonary malignancies. Power (10-32 W) and frequency (908-928 MHz) were continuously adjusted by the generator to maintain a temperature of 110°-120°C at the 14-gauge antenna tip for one 10-minute application. After testing for an air leak, tumors were resected surgically. Gross inspection, slicing, and hematoxylin-eosin (10 specimens) and nicotinamide adenine dinucleotide (six specimens) staining were performed.
RESULTS: Tumors included adenocarcinomas (n = 5), squamous cell carcinomas (n = 3), and metastases from endometrial (n = 1) and colorectal (n = 1) primary carcinomas. Mean maximum tumor diameter was 2.4 cm (range, 0.9-5.0 cm), and mean maximum volume was 8.6 cm(3) (range, 0.5-52.7 cm(3)). One air leak was detected. Five of 10 specimens were grossly measurable, revealing a mean maximum ablation zone diameter of 4.8 cm (range, 3.0-6.5 cm) and a mean maximum ablation zone volume of 15.1 cm(3) (range, 7.3-25.1 cm(3)). At hematoxylin-eosin staining, coagulation necrosis was observed in all ablation zones, extended into the normal lung in nine of 10 specimens, and up to blood vessel walls without evidence of vessel (>4 mm) thrombosis. Nicotinamide adenine dinucleotide staining enabled confirmation of no viability within ablation zones extending into normal lung in five of six specimens.
CONCLUSION: MWA with tumor permittivity feedback control results in cytotoxic intratumoral temperatures and extension of ablation zones into aerated peritumoral pulmonary parenchyma, possibly forming the equivalent of an oncologic resection margin. © RSNA, 2011.

Entities:  

Mesh:

Year:  2011        PMID: 22106348     DOI: 10.1148/radiol.11110015

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases.

Authors:  I Kurilova; A Gonzalez-Aguirre; R G Beets-Tan; J Erinjeri; E N Petre; M Gonen; M Bains; N E Kemeny; S B Solomon; C T Sofocleous
Journal:  Cardiovasc Intervent Radiol       Date:  2018-05-29       Impact factor: 2.740

2.  Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation.

Authors:  Lou Zhong; Siyuan Sun; Jiahai Shi; Fei Cao; Xiao Han; Xueping Bao; Qingsheng You
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 3.  Thermal ablation of malignant lung tumors.

Authors:  Thomas Schneider; Claus Peter Heussel; Felix J F Herth; Hendrik Dienemann
Journal:  Dtsch Arztebl Int       Date:  2013-05-31       Impact factor: 5.594

4.  Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases.

Authors:  Xia Yang; Xin Ye; Aimin Zheng; Guanghui Huang; Xiang Ni; Jiao Wang; Xiaoying Han; Wenhong Li; Zhigang Wei
Journal:  J Surg Oncol       Date:  2014-06-25       Impact factor: 3.454

5.  Intra-operative microwave ablation of liver malignancies with tumour permittivity feedback control: a prospective ablate and resect study.

Authors:  Linda Ratanaprasatporn; Kevin P Charpentier; Murray Resnick; Shaolei Lu; Damian Dupuy
Journal:  HPB (Oxford)       Date:  2013-03-29       Impact factor: 3.647

Review 6.  Modern diagnostic and therapeutic interventional radiology in lung cancer.

Authors:  Wai-Kit Lee; Eddie W F Lau; Kwang Chin; Oliver Sedlaczek; Karin Steinke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 7.  Microwave ablation: state-of-the-art review.

Authors:  José Irving Hernández; Mario Francisco Jesús Cepeda; Francisco Valdés; Geshel David Guerrero
Journal:  Onco Targets Ther       Date:  2015-07-06       Impact factor: 4.147

8.  The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism.

Authors:  Po-Chin Liang; Hong-Shiee Lai; Tiffany Ting-Fang Shih; Chih-Horng Wu; Kai-Wen Huang
Journal:  BMC Surg       Date:  2014-10-22       Impact factor: 2.102

9.  Comparison of real-time contrast-enhanced ultrasonography and standard ultrasonography in liver cancer microwave ablation.

Authors:  Shi-Yan Yan; Yi Zhang; Chao Sun; Hai-Xia Cao; Guang-Ming Li; Yu-Qin Wang; Jian-Gao Fan
Journal:  Exp Ther Med       Date:  2016-06-10       Impact factor: 2.447

10.  Clinical Application of CT-Guided Percutaneous Microwave Ablation for the Treatment of Lung Metastasis from Colorectal Cancer.

Authors:  Lin Li; Ketong Wu; Haiyang Lai; Bo Zhang
Journal:  Gastroenterol Res Pract       Date:  2017-10-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.